The Lancet – Published: November 1, 2016
Breast and cervical cancers receive far less funding, advocacy, and public and political attention in low-income and middle-income countries (LMICs) than in high-income countries (HICs). Yet women in these settings have higher burdens of these diseases, poorer access to care, present with more advanced stages of disease, and are more likely to die from their disease than women in HICs. The Lancet Series, Health, equity, and women’s cancers, explores this neglected global health issue. The papers cover the global burden of breast and cervical cancers and inequities in their incidence, survival, and mortality; interventions that could close the divide between resource-rich countries and LMICs; and the changes to global policy that are needed to deliver safe, equitable, and affordable care for women.